HARVARD BIOSCIENCE, INC. Tax Withholding Paid on Stock Awards
HARVARD BIOSCIENCE, INC. (HBIO) reported Tax Withholding Paid on Stock Awards of $66.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $36.00K.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $30.00K, a 60.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $57.00K, a 89.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $24.00K.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $156.00K, a 72.96% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $577.00K, a 77.13% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.52M, a 54.98% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.63M, a 53.67% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $66.00K 10-Q · filed 2026-08-11 | $123.00K derived: sum of 3 quarters · filed 2026-08-11 | $147.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-12 | $87.00K derived: sum of 2 quarters · filed 2026-05-12 | $111.00K derived: sum of 3 quarters · filed 2026-05-12 | $111.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $81.00K derived: sum of 2 quarters · filed 2026-03-13 | $81.00K derived: sum of 3 quarters · filed 2026-08-11 | $156.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $24.00K derived: sum of 2 quarters · filed 2026-08-11 | $99.00K 10-Q · filed 2025-11-06 | $617.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $75.00K 10-Q · filed 2026-08-11 | $593.00K derived: sum of 3 quarters · filed 2026-08-11 | $593.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $75.00K 10-Q · filed 2026-05-12 | $593.00K derived: sum of 2 quarters · filed 2026-05-12 | $593.00K derived: sum of 3 quarters · filed 2026-05-12 | $605.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $518.00K derived: sum of 2 quarters · filed 2026-03-13 | $530.00K derived: sum of 3 quarters · filed 2026-03-13 | $577.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $12.00K derived: sum of 2 quarters · filed 2025-11-06 | $59.00K 10-Q · filed 2025-11-06 | $2.13M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $59.00K 10-Q · filed 2025-08-11 | $2.13M derived: sum of 3 quarters · filed 2025-08-11 | $2.13M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $47.00K 10-Q · filed 2025-05-12 | $2.12M derived: sum of 2 quarters · filed 2025-05-12 | $2.12M derived: sum of 3 quarters · filed 2025-05-12 | $2.41M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $2.07M derived: sum of 2 quarters · filed 2025-03-14 | $2.37M derived: sum of 3 quarters · filed 2025-03-14 | $2.52M 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $295.00K derived: sum of 2 quarters · filed 2024-11-08 | $451.00K 10-Q · filed 2024-11-08 | $912.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $451.00K 10-Q · filed 2024-08-08 | $912.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.30M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $156.00K 10-Q · filed 2024-05-07 | $617.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.00M derived: sum of 3 quarters · filed 2024-05-07 | $1.28M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $848.00K derived: sum of 2 quarters · filed 2024-03-07 | $1.13M derived: sum of 3 quarters · filed 2024-03-07 | $1.63M 10-K · filed 2024-03-07 |
| 2022-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $666.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.17M 10-Q · filed 2023-11-07 | $2.03M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $279.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $780.00K 10-Q · filed 2023-08-08 | $1.64M derived: sum of 3 quarters · filed 2023-08-08 | $3.30M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $501.00K 10-Q · filed 2023-04-26 | $1.36M derived: sum of 2 quarters · filed 2023-04-26 | $3.02M derived: sum of 3 quarters · filed 2023-04-26 | $3.55M derived: sum of 4 quarters · filed 2023-04-26 |
| 2021-12-31 | $861.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.52M derived: sum of 2 quarters · filed 2023-03-09 | $3.05M derived: sum of 3 quarters · filed 2023-03-09 | $3.51M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.19M derived: sum of 2 quarters · filed 2022-11-09 | $2.65M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $990.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $464.00K 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $1.14M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |